ObjectivesThe purpose of the study was to assess the cardiovascular risk of impaired fasting glucose (IFG).BackgroundThe associations between IFG, incident type 2 diabetes mellitus (T2DM), and cardiovascular (CV) events remains unclear.MethodsThe MESA (Multi-Ethnic Study of Atherosclerosis) study included participants who were 45 to 84 years or age and free of clinical CV disease at baseline (2000 to 2002). Type 2 DM was defined as fasting glucose >125 mg/dl or receiving antidiabetes medication at baseline and follow-up examinations; IFG was defined as no T2DM and fasting glucose 100 to 125 mg/dl. Cox proportional hazards analysis was used to assess the association between IFG and incident DM and also between IFG and incident CV events.Resu...
Background. Impaired fasting glucose (IFG) through the nondiabetic range (100–125 mg/dL) is not cons...
Trials of intensive glucose control have not improved cardiovascular disease (CVD) risk in populatio...
Trials of intensive glucose control have not improved cardiovascular disease (CVD) risk in populatio...
ObjectivesThe purpose of the study was to assess the cardiovascular risk of impaired fasting glucose...
Objective: Most previous studies on cardiovascular health (CVH) and incident type 2 diabetes (T2D) h...
Objective: Most previous studies on cardiovascular health (CVH) and incident type 2 diabetes (T2D) h...
Objective: Most previous studies on cardiovascular health (CVH) and incident type 2 diabetes (T2D) h...
OBJECTIVE: Although diabetes increases the risk of cardiovascular disease (CVD) and mortality, the d...
ObjectivesWe sought to determine whether impaired fasting glucose (IFG) predicts cardiovascular dise...
Aims: To detect the risk factors of diabetes mellitus (DM) and cardiovascular complications in subje...
Background Metabolic abnormalities, such as impaired fasting glucose (IFG), are dynamic phenomena; h...
© 2015 The American Geriatrics Society. Objectives To examine whether impaired fasting glucose (IFG)...
ObjectivesThe goals of this study were to assess the effect of the 2003 American Diabetes Associatio...
Objectives: To investigate glucose levels as a risk factor for unrecognized myocardial infarctions (...
Objectives: To investigate glucose levels as a risk factor for unrecognized myocardial infarctions (...
Background. Impaired fasting glucose (IFG) through the nondiabetic range (100–125 mg/dL) is not cons...
Trials of intensive glucose control have not improved cardiovascular disease (CVD) risk in populatio...
Trials of intensive glucose control have not improved cardiovascular disease (CVD) risk in populatio...
ObjectivesThe purpose of the study was to assess the cardiovascular risk of impaired fasting glucose...
Objective: Most previous studies on cardiovascular health (CVH) and incident type 2 diabetes (T2D) h...
Objective: Most previous studies on cardiovascular health (CVH) and incident type 2 diabetes (T2D) h...
Objective: Most previous studies on cardiovascular health (CVH) and incident type 2 diabetes (T2D) h...
OBJECTIVE: Although diabetes increases the risk of cardiovascular disease (CVD) and mortality, the d...
ObjectivesWe sought to determine whether impaired fasting glucose (IFG) predicts cardiovascular dise...
Aims: To detect the risk factors of diabetes mellitus (DM) and cardiovascular complications in subje...
Background Metabolic abnormalities, such as impaired fasting glucose (IFG), are dynamic phenomena; h...
© 2015 The American Geriatrics Society. Objectives To examine whether impaired fasting glucose (IFG)...
ObjectivesThe goals of this study were to assess the effect of the 2003 American Diabetes Associatio...
Objectives: To investigate glucose levels as a risk factor for unrecognized myocardial infarctions (...
Objectives: To investigate glucose levels as a risk factor for unrecognized myocardial infarctions (...
Background. Impaired fasting glucose (IFG) through the nondiabetic range (100–125 mg/dL) is not cons...
Trials of intensive glucose control have not improved cardiovascular disease (CVD) risk in populatio...
Trials of intensive glucose control have not improved cardiovascular disease (CVD) risk in populatio...